» Authors » L Trojan

L Trojan

Explore the profile of L Trojan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 33
Citations 223
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Reichert M, Schuler P, Stepniewski A, Felmerer G, Trojan L, von Knobloch H
Urologie . 2022 Sep; 62(3):295-298. PMID: 36066612
When taking into consideration the basic principles of fistula surgery, numerous options are available for the surgical repair of rectourethral fistulas. However, there is no standard regarding which surgical method...
2.
Martinschek A, Welzel G, Ritter M, Heinrich E, Bolenz C, Trojan L
J Robot Surg . 2018 Mar; 12(4):673-678. PMID: 29550992
To prospectively evaluate the possible loss of attention among console surgeons performing robotic-assisted procedures using a validated psychological test. The concentration of one console surgeon was assessed before and after...
3.
Waegner R, Schmid M, Trojan L, Ahyai S
Urologe A . 2016 Jun; 55(6):756-62. PMID: 27294488
Background: Retroperitoneal endometriosis is a common benign disease, which requires an interdisciplinary approach. In the clinical practice diagnosis is often delayed for years after onset of the unspecific symptoms so...
4.
Meller B, Bremmer F, Sahlmann C, Hijazi S, Bouter C, Trojan L, et al.
EJNMMI Res . 2015 Nov; 5(1):66. PMID: 26576996
Background: Prostate-specific membrane antigen (PSMA) is a promising target for diagnostics and therapy of prostate carcinoma (PCa). Based on the hypothesis that PSMA expression can be modulated by variations in...
5.
Hijazi S, Meller B, Leitsmann C, Strauss A, Meller J, Ritter C, et al.
Prostate . 2015 Sep; 75(16):1934-40. PMID: 26356236
Background: The first evaluation of pelvic extended lymph node dissection (pLND) in oligometastatic prostate cancer (PCa) detected by (68)Ga-PSMA PET/CT. Methods: Retrospective analysis of 35 PCa patients underwent (68)Ga-PSMA PET/CT...
6.
Martinschek A, Pfalzgraf D, Rafail B, Ritter M, Heinrich E, Trojan L
World J Urol . 2015 Sep; 34(3):407-11. PMID: 26337521
Objective: To evaluate urethral catheter (UC) versus suprapubic tube (SPT) without stenting the anastomosis at robot-assisted radical prostatectomy (RALP) regarding surgical outcome and catheter-associated discomfort. One year after surgery, continence...
7.
Zemlickova H, Dedicova D, Jakubu V, Mach J, Kolinska R, Malikova E, et al.
Epidemiol Mikrobiol Imunol . 2013 Aug; 62(2):43-9. PMID: 23964964
Study Aim: To determine antibiotic resistance and incidence of multidrug resistance among Nontyphoidal salmonellae serovars isolated from humans. Material And Methods: Consecutive Salmonella isolates from patients, recovered in 48 microbiology...
8.
Gierth M, Fritsche H, Buchner H, May M, Aziz A, Otto W, et al.
World J Urol . 2013 Jun; 32(2):365-71. PMID: 23736527
Purpose: Radical cystectomy (RC) and pelvic lymph node dissection (LND) are standard treatments for muscle-invasive urothelial carcinoma of the bladder. Lymph node staging is a prerequisite for clinical decision-making regarding...
9.
Buchner A, May M, Burger M, Bolenz C, Herrmann E, Fritsche H, et al.
Eur J Surg Oncol . 2013 Mar; 39(4):372-9. PMID: 23465180
Aim: The outcome of patients with urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC) shows remarkable variability. We evaluated the ability of artificial neural networks (ANN) to perform...
10.
Nuhn P, May M, Fritsche H, Buchner A, Brookman-May S, Bolenz C, et al.
Eur J Surg Oncol . 2012 Mar; 38(7):637-42. PMID: 22459902
Purpose: To perform the first external validation of a recently identified association between disease-free survival at two years (DFS2) or three years (DFS3) and overall survival at five years (OS5)...